---
title: "Ping An Biomedical Shareholders Approve Dual‑Class Structure and Major Share Consolidation at 2026 AGM"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279816757.md"
description: "Ping An Biomedical Shareholders Approve Dual‑Class Structure and Major Share Consolidation at 2026 AGM"
datetime: "2026-03-19T15:17:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279816757.md)
  - [en](https://longbridge.com/en/news/279816757.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279816757.md)
---

# Ping An Biomedical Shareholders Approve Dual‑Class Structure and Major Share Consolidation at 2026 AGM

Ping An Biomedical Shareholders Approve Dual‑Class Structure and Major Share Consolidation at 2026 AGM

### Related Stocks

- [PASW.US](https://longbridge.com/en/quote/PASW.US.md)

## Related News & Research

- [A Look At UroGen Pharma (URGN) Valuation After New UGN-103 And ZUSDURI Bladder Cancer Data](https://longbridge.com/en/news/286722721.md)
- [TGT Stock Alert: What to Know as Target Taps Former Walmart Exec](https://longbridge.com/en/news/286957668.md)
- [Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares](https://longbridge.com/en/news/286950631.md)
- [Should you invest $1,000 in AGNC Investment right now?](https://longbridge.com/en/news/286802595.md)
- [Akari Therapeutics prices $5.5 million unregistered private placement at $3.74 ADS](https://longbridge.com/en/news/287221750.md)